Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
93 Leser
Artikel bewerten:
(0)

Canaccord Genuity Group Inc - Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

TORONTO, October 2, 2015 - Canaccord Genuity Group Inc. (the "Company") announces that on October 1, 2015, the Company was notified, in accordance with DTR3.1.2R, that common shares were acquired by the following persons discharging managerial responsibility and connected persons, pursuant to the acquisition of common shares on the vesting of restricted share units (RSUs) held under the Company's long term incentive plan, and purchases in the open market. Common shares were also sold to cover tax liabilities.


Name of Person Discharging Managerial Responsibility
Number of common shares issued on vesting of RSUsNumber of common shares purchased in the open marketNumber of common shares sold to cover tax liabilitiesAverage price per shareTotal and percentage of common shares held after the acquisition and sale
Alexis de Rosnay120,000--56,004CAD$5.23149194,363 / 0.19%
Terry Lyons-- 5,500*--CAD$5.247937,988* / 0.037%

*The figure above includes shareholdings acquired / owned by Mr. Lyons' spouse.

ABOUT CANACCORD GENUITY GROUP INC.:

Through its principal subsidiaries, Canaccord Genuity Group Inc. (the "Company") is a leading independent, full-service financial services firm, with operations in two principal segments of the securities industry: wealth management and capital markets. Since its establishment in 1950, the Company has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual, institutional and corporate clients through comprehensive investment solutions, brokerage services and investment banking services. The Company has offices in 10 countries worldwide, including Wealth Management offices located in Canada, Australia, the UK, Guernsey, Jersey, and the Isle of Man. Canaccord Genuity, the international capital markets division, operates in Canada, the US, the UK, France, Ireland, Hong Kong, China, Singapore, Australia and Barbados. To us there are no foreign markets.TM

Canaccord Genuity Group Inc. is publicly traded under the symbol CF on the TSX and the symbol CF. on the London Stock Exchange.

FOR FURTHER INFORMATION CONTACT:

North America media:
Scott Davidson
Executive Vice President, Global Head of Corporate Development and Strategy
Phone: 416-869-3875, email: scott.davidson@canaccord.com

For investor relations inquiries contact:
Christina Marinoff
Vice President, Investor Relations & Communications
Phone: 416-687-5507, email: christina.marinoff@canaccord.com

London media:
Robert Morgan
Stockwell
Phone: +44 (0) 20 7240 2486, email: robert.morgan@stockwellgroup.com

Brokers:
Oliver Hearsey
RBC Europe Limited
Phone: +44 (0) 20 7653 4000, email: oliver.hearsey@rbccm.com

Simon Hardy or Alex Collins
Jefferies International Limited
Phone: +44 (0) 20 7029 8000, email: simon.hardy@jefferies.com;
alex.collins@jefferies.com

(CF. CF)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.